Amie C. Shei, Ph.D.

Affiliations: 
2011 Harvard University, Cambridge, MA, United States 
Google:
"Amie Shei"

Parents

Sign in to add mentor
David M. Cutler grad student 2011 Harvard
 (The health impacts of public programs for the poor in Brazil and the United States.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shei A, Rice B, Kirson NY, et al. (2015) Characteristics of High-Cost Patients Diagnosed with Opioid Abuse. Journal of Managed Care & Specialty Pharmacy. 21: 902-12
Shei A, Hirst M, Kirson NY, et al. (2015) Estimating the health care burden of prescription opioid abuse in five European countries. Clinicoeconomics and Outcomes Research : Ceor. 7: 477-88
Kirson NY, Shei A, Rice JB, et al. (2015) The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals. Pain Medicine (Malden, Mass.). 16: 1325-32
Shei A, Rice JB, Kirson NY, et al. (2015) Sources of prescription opioids among diagnosed opioid abusers. Current Medical Research and Opinion. 31: 779-84
Kirson NY, Shei A, Birnbaum HG, et al. (2014) Medical resource use and costs among pain patients with potential opioid-tolerability issues. Journal of Opioid Management. 10: 305-10
Rice JB, Kirson NY, Shei A, et al. (2014) The economic burden of diagnosed opioid abuse among commercially insured individuals. Postgraduate Medicine. 126: 53-8
Kirson NY, Shei A, White AG, et al. (2014) Societal economic benefits associated with an extended-release opioid with abuse-deterrent technology in the United States. Pain Medicine (Malden, Mass.). 15: 1450-4
Rice JB, Kirson NY, Shei A, et al. (2014) Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data. Applied Health Economics and Health Policy. 12: 435-46
Michna E, Kirson NY, Shei A, et al. (2014) Use of prescription opioids with abuse-deterrent technology to address opioid abuse. Current Medical Research and Opinion. 30: 1589-98
Rossiter LF, Kirson NY, Shei A, et al. (2014) Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US. Journal of Medical Economics. 17: 279-87
See more...